In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure

High dose bee venom exposure in beekeepers by natural bee stings represents a model to understand mechanisms of T cell tolerance to allergens in healthy individuals. Continuous exposure of nonallergic beekeepers to high doses of bee venom antigens induces diminished T cell–related cutaneous late-pha...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 205; no. 12; pp. 2887 - 2898
Main Authors Meiler, Flurina, Zumkehr, Judith, Klunker, Sven, Rückert, Beate, Akdis, Cezmi A., Akdis, Mübeccel
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 24.11.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:High dose bee venom exposure in beekeepers by natural bee stings represents a model to understand mechanisms of T cell tolerance to allergens in healthy individuals. Continuous exposure of nonallergic beekeepers to high doses of bee venom antigens induces diminished T cell–related cutaneous late-phase swelling to bee stings in parallel with suppressed allergen-specific T cell proliferation and T helper type 1 (Th1) and Th2 cytokine secretion. After multiple bee stings, venom antigen–specific Th1 and Th2 cells show a switch toward interleukin (IL) 10–secreting type 1 T regulatory (Tr1) cells. T cell regulation continues as long as antigen exposure persists and returns to initial levels within 2 to 3 mo after bee stings. Histamine receptor 2 up-regulated on specific Th2 cells displays a dual effect by directly suppressing allergen-stimulated T cells and increasing IL-10 production. In addition, cytotoxic T lymphocyte–associated antigen 4 and programmed death 1 play roles in allergen-specific T cell suppression. In contrast to its role in mucosal allergen tolerance, transforming growth factor β does not seem to be an essential player in skin-related allergen tolerance. Thus, rapid switch and expansion of IL-10–producing Tr1 cells and the use of multiple suppressive factors represent essential mechanisms in immune tolerance to a high dose of allergens in nonallergic individuals.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
F. Meiler and J. Zumkehr contributed equally to this paper.
Abbreviations used: CTLA, CTL-associated antigen; HR, histamine receptor; PD, programmed death; PLA, phospholipase A2; PPD, purified protein derivative; SIT, specific immunotherapy; TCRVβ, TCR variable β; Tr1, type 1 T regulatory; TT, tetanus toxoid.
CORRESPONDENCE Mübeccel Akdis: akdism@siaf.unizh.ch
ISSN:0022-1007
1540-9538
1540-9538
DOI:10.1084/jem.20080193